These findings demonstrate that RGS6, a protein previously linked to reduced UBC risk, is highly expressed in the urothelium where approximately 90% of UBCs arise and that RGS6−/− mice can be employed to study its tumor suppressor role in bladder. Here, RGS6 is linked to neoplasm.